Reduced expression of FILIP1L, a novel WNT pathway inhibitor, is associated with poor survival, progression and chemoresistance in ovarian cancer

Filamin A interacting protein 1-like (FILIP1L) is an inhibitor of the canonical WNT pathway. WNT/β-catenin signaling and its downstream pathway, epithelial-to-mesenchymal transition (EMT), play a key role in ovarian cancer metastasis and chemoresistance. To study the clinical implications of FILIP1L...

Descripción completa

Detalles Bibliográficos
Autores principales: Kwon, Mijung, Kim, Jae-Hoon, Rybak, Yevangelina, Luna, Alex, Choi, Chel Hun, Chung, Joon-Yong, Hewitt, Stephen M., Adem, Asha, Tubridy, Elizabeth, Lin, Juan, Libutti, Steven K.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2016
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5340232/
https://www.ncbi.nlm.nih.gov/pubmed/27776341
http://dx.doi.org/10.18632/oncotarget.12784

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5340232/
https://www.ncbi.nlm.nih.gov/pubmed/27776341
http://dx.doi.org/10.18632/oncotarget.12784

Ejemplares similares